Volume 120, Issue 4 , Pages 856-862, October 2007
An electronic nose in the discrimination of patients with asthma and controls
Background
Exhaled breath contains thousands of volatile organic compounds (VOCs) that could serve as biomarkers of lung disease. Electronic noses can distinguish VOC mixtures by pattern recognition.
Objective
We hypothesized that an electronic nose can discriminate exhaled air of patients with asthma from healthy controls, and between patients with different disease severities.
Methods
Ten young patients with mild asthma (25.1 ± 5.9 years; FEV1, 99.9 ± 7.7% predicted), 10 young controls (26.8 ± 6.4 years; FEV1, 101.9 ± 10.3), 10 older patients with severe asthma (49.5 ± 12.0 years; FEV1, 62.3 ± 23.6), and 10 older controls (57.3 ± 7.1 years; FEV1, 108.3 ± 14.7) joined a cross-sectional study with duplicate sampling of exhaled breath with an interval of 2 to 5 minutes. Subjects inspired VOC-filtered air by tidal breathing for 5 minutes, and a single expiratory vital capacity was collected into a Tedlar bag that was sampled by electronic nose (Cyranose 320) within 10 minutes. Smellprints were analyzed by linear discriminant analysis on principal component reduction. Cross-validation values (CVVs) were calculated.
Results
Smellprints of patients with mild asthma were fully separated from young controls (CVV, 100%; Mahalanobis distance [M-distance], 5.32), and patients with severe asthma could be distinguished from old controls (CVV, 90%; M-distance, 2.77). Patients with mild and severe asthma could be less well discriminated (CVV, 65%; M-distance, 1.23), whereas the 2 control groups were indistinguishable (CVV, 50%; M-distance, 1.56). The duplicate samples replicated these results.
Conclusion
An electronic nose can discriminate exhaled breath of patients with asthma from controls but is less accurate in distinguishing asthma severities.
Clinical implication
These findings warrant validation of electronic noses in diagnosing newly presented patients with asthma.
Key words: Asthma mild, asthma severe, biomarkers, diagnosis, electronic nose, exhaled breath, volatile organic compounds
Abbreviations used: CVV, Cross-validation value, FVC, Forced vital capacity, GC-MS, Gas chromatography and mass spectrometry, M-distance, Mahalanobis distance, PCA, Principal component analysis, SPT, Skin prick test, VOC, Volatile organic compound
Supported by Leiden University Medical Center, The Netherlands, and the University of Bari, Italy.
Disclosure of potential conflict of interest: The authors have declared that they have no conflict of interest.
PII: S0091-6749(07)01038-X
doi:10.1016/j.jaci.2007.05.043
© 2007 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 120, Issue 4 , Pages 856-862, October 2007
